ALTO NEUROSCIENCE - TO ACCELERATE AND EXPAND CLINICAL DEVELOPMENT OF ALTO-207 WITH ADDITIONAL PLANNED PHASE 3 TRIAL - SEC FILING

Reuters · 3d ago

Please log in to view news